ArticleCureus2025
Severe Myxedema Coma With Neurological, Cardiac, and Renal Involvement: A Case Report.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Myxedema coma is the most severe manifestation of hypothyroidism, with high mortality despite treatment. It typically affects elderly women and is often triggered by infection, drug exposure, or environmental stressors. We report the case of a 66-year-old woman with no prior history of thyroid disease who presented with progressive neurological deterioration, hypothermia, bradycardia, hypotension, and multiorgan dysfunction. Laboratory evaluation confirmed severe hypothyroidism with elevated thyroid-stimulating hormone and undetectable free T4, alongside markedly elevated cardiac enzymes, global cardiomyopathy with pericardial effusion, and acute kidney injury. Management with high-dose enteral levothyroxine and intravenous hydrocortisone, in combination with supportive care, led to rapid improvement, extubation by day three, and full recovery of thyroid, cardiac, renal, and neurological function. This case underscores the importance of early recognition and timely intervention in patients with unexplained encephalopathy and systemic compromise, as prompt treatment can reverse even severe presentations of myxedema coma.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.